Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
Eli Lilly Stock Falls. Novo Extends Lead in Weight-Loss Drug Race
12:53pm, Friday, 24'th Apr 2026
Eli Lilly (LLY) shares fell about 4% on Friday after data indicated its obesity drug prescriptions were trailing those of rival Novo Nordisk.Eli Lilly's weekly
Eli Lilly Slips as Obesity Prescriptions Lag
12:12pm, Friday, 24'th Apr 2026
Eli Lilly (LLY, Financials) slipped in premarket trading after prescription data showed its obesity treatments trailing rival Novo Nordisk's Wegovy.For the week
Lilly's obesity pill hits nearly 4000 prescriptions in second week after launch
08:14am, Friday, 24'th Apr 2026
Eli Lilly's newly launched oral weight loss drug was prescribed 3,707 times in the U.S. in the second week after its launch earlier this month, according to analysts citing IQVIA data.
Eli Lilly (LLY) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Thursday, 23'rd Apr 2026
Lilly (LLY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Eli Lilly (LLY) Declines More Than Market: Some Information for Investors
06:46pm, Tuesday, 21'st Apr 2026
Eli Lilly (LLY) concluded the recent trading session at $903.02, signifying a -1.83% move from its prior day's close.
Eli Lilly's Kelonia Therapeutics acquisition seen as strategic bet on next-generation CAR-T: analysts
04:06pm, Tuesday, 21'st Apr 2026
Eli Lilly and Co (NYSE:LLY)'s acquisition of Kelonia Therapeutics is being seen as a positive step for long-term pipeline building, even as the target's lead assets remain in early clinical developmen
LLY to Buy Oncology Biotech Kelonia Therapeutics for $7 Billion
12:42pm, Tuesday, 21'st Apr 2026
Eli Lilly is set to acquire Kelonia Therapeutics in a $7B deal, boosting its genetic medicine platform with a novel in vivo CAR-T therapy for cancer.
Eli Lilly and Company $LLY Shares Bought by CM Wealth Advisors LLC
05:38am, Tuesday, 21'st Apr 2026
CM Wealth Advisors LLC lifted its position in Eli Lilly and Company (NYSE: LLY) by 72.0% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchan
Argo Wealth Advisory LLC Buys New Position in Eli Lilly and Company $LLY
05:00am, Tuesday, 21'st Apr 2026
Argo Wealth Advisory LLC bought a new stake in shares of Eli Lilly and Company (NYSE: LLY) during the undefined quarter, according to the company in its most recent disclosure with the Securities and
Monday's Final Takeaways: LLY New Acquisition & AAL Shuts Down UAL Bid
04:47pm, Monday, 20'th Apr 2026
Eli Lilly's (LLY) $7 billion acquisition of Kelonia Therapeutics and American Airlines (AAL) denying a United Airlines (UAL) acquisition bid take Sam Vadas and Marley Kayden's attention for Monday's f
Eli Lilly: We Haven't Reached Its Peak Yet (Rating Upgrade)
03:38pm, Monday, 20'th Apr 2026
Eli Lilly: We Haven't Reached Its Peak Yet (Rating Upgrade)
Eli Lilly Goes Atomic—But This Isn't About AI Servers
12:24pm, Monday, 20'th Apr 2026
The drugmaker behind Prozac and Cialis is now exploring nuclear energy, signing a letter of intent with Indiana to support small modular reactors and advanced nuclear tech. The signal here isn't about
Eli Lilly: From Sell To Buy In 90 Days, Here's What Changed My Mind
12:04pm, Monday, 20'th Apr 2026
Eli Lilly is upgraded to Buy after a 13% pullback and strong Q4 guidance, with potential for 25% topline growth in 2026. LLY's acquisition of Kelonia and Orna Therapeutics positions it at the forefron
Eli Lilly to buy Kelonia Therapeutics in up to $7 billion cancer immunotherapy drug deal
11:26am, Monday, 20'th Apr 2026
CNBC's Angelica Peebles reports the latest news on pharmaceuticals.
Eli Lilly expands genetic medicine capabilities with Kelonia Therapeutics acquisition
11:07am, Monday, 20'th Apr 2026
Eli Lilly and Co (NYSE:LLY) has agreed to acquire private clinical-stage biotechnology firm Kelonia Therapeutics in a deal aimed at expanding its capabilities in genetic medicines, the companies annou
